Inactive Instrument

Nu-Med Plus Inc Share Price OTC Bulletin Board

Equities

US67021R1041

Medical Equipment, Supplies & Distribution

End-of-day quote OTC Bulletin Board
- USD - Intraday chart for Nu-Med Plus Inc
Sales 2022 - Sales 2023 - Capitalization 3.38M 266M
Net income 2022 - 0 Net income 2023 - 0 EV / Sales 2022 -
Net Debt 2022 26.8K 2.11M Net Debt 2023 93.19K 7.33M EV / Sales 2023 -
P/E ratio 2022
-10.1 x
P/E ratio 2023
-26.3 x
Employees -
Yield 2022 *
-
Yield 2023
-
Free-Float 54.96%
More Fundamentals * Assessed data
Nu-Med Plus, Inc. completed the acquisition of Your Space, Inc. from William R. Colvin, Robert Papri, Arthur Hood, William Hayde, and Dan Bittner. CI
Nu-Med Plus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Nu-Med Plus, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Nu-Med Plus, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Nu-Med Plus, Inc. entered into a letter of intent to acquire Your Space, Inc. from William R. Colvin, Robert Papri, Arthur Hood, William Hayde, and Dan Bittner. CI
Nu-Med Plus, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Nu-Med Plus, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Nu-Med Plus, Inc. Auditor Raises 'Going Concern' Doubt CI
Nu-Med Plus, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Nu-Med Plus, Inc. announced that it has received $0.1 million in funding from Your Space, Inc CI
Nu-Med Plus, Inc. Appoints Jeffrey L. Robins to the Board of Director CI
Nu-Med Plus, Inc. Announces Management Changes CI
Nu-Med Plus, Inc. Announces Management Changes CI
Nu-Med Plus, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Nu-Med Plus, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
More news
Managers TitleAgeSince
Chairman 59 11/09/22
Director of Finance/CFO 78 31/07/15
Members of the board TitleAgeSince
Director of Finance/CFO 78 31/07/15
Chief Executive Officer 75 -
Chairman 59 11/09/22
More insiders
Nu-Med Plus, Inc. is a medical device company, which is principally engaged in the designing, development, enhancement and commercialization of later-stage medical devices. The Company is focused on the creation of a nitric oxide generating formulation, a hospital bedside nitric oxide (NO) delivery system, a clinical unit for use in medical clinics and rehabilitation centers and a mobile rechargeable device to deliver nitric oxide gas to offer solutions to hospitals, health systems and the medical community throughout the world. Hospital NO Unit delivers a continuous intra-breath concentration of therapeutic NO to patients who are on a ventilator in a hospital setting. Clinical Delivery System is a simplified version of the hospital unit. Portable Delivery System delivers high purity NO to the patient at prescribed intervals for 24 hours per day at controlled doses by means of a nasal cannula or a face mask. Reagent Delivery provides a range of concentrations and flow rates of NO.
More about the company